Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Board Changes

24 Jul 2018 07:00

RNS Number : 5122V
System1 Group PLC
24 July 2018
Β 

Β 

Β 

Β 

Press Release

24 July 2018

Β 

System1 Group PLC (AIM: SYS1)

formerly BrainJuicer Group PLC

("System1", or "the Company")

Β 

Board Changes

Β 

System1 announces the appointment of Jane Caroline Wakely (47), as a Non-Executive Director of the Company with immediate effect.

Β 

Jane is currently Global Chief Marketing Officer for Pet Nutrition at Mars Incorporated. In this role she is accountable for the Pet Nutrition brand portfolio, marketing and digital strategy globally. She has been at Mars for 17 years, was recently a finalist in the WFA's (World Federation of Advertisers) Global Marketer of the Year 2017 award - recognised for her creative leadership, purpose marketing and evidence based approach to growth. Prior to joining Mars, Jane worked for Procter & Gamble for almost a decade where she worked in marketing across brands in the Health and Beauty Care division. Jane is a Chartered Management Accountant and holds a BSc (Hons) in Business Administration from Bath Spa University.

Β 

Jane does not hold any shares in the Company. Other than disclosed above, there are no disclosures required in relation to Rule 17 or paragraph (g) of Schedule 2 of the AIM Rules for Companies.

Β 

With effect from 25 July 2018, following the Company's Annual General Meeting at which Ken Ford, Chairman, is retiring, Graham Blashill is appointed Chairman of the Board, and Robert Brand as Senior Independent Director. Following the recent appointment of Sophie Tomkins announced on 11 June 2018, this completes the planned reconstitution of the Board. Going forward, the Board will comprise four independent Non-Executive Directors, and three Executive Directors, and has a balance of skills, experience and independence.

Β 

Commenting on the new appointments, John Kearon, Chief Executive Officer, said, "I am delighted to welcome Jane and Sophie to the Board. Jane's expertise in applying behavioural science and creative excellence to marketing at one of the world's preeminent packaged goods companies will be invaluable as we develop our offering to help clients create 5 Star marketing. Sophie is a high calibre leader and her substantial experience in governance and in the public financial markets will also be of great value to the Board as we look forward to building the business in the coming years."

Β 

The Company can be found at www.system1group.com.

Β 

For further information, please contact:

System1 Group PLC

Tel: +44 (0)20 7043 1000

Β 

John Kearon, Chief Executive Officer

Β 

James Geddes, Chief Financial Officer

Β 

Canaccord Genuity Limited

Tel: +44 (0)20 7523 8000

Simon Bridges / Emma Gabriel

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
BOARJMBTMBJTTRP
Date   Source Headline
1st May 20264:30 pmRNSHolding(s) in Company
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
21st Apr 20267:00 amRNSQ4 and Full Year Trading Update
9th Apr 20267:00 amRNS-RLaunch of next evolution of Test Your Ad platform
30th Mar 20264:30 pmRNSHolding(s) in Company
30th Mar 20263:30 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTrading Update
16th Mar 20267:00 amRNSTrading Update
5th Mar 20263:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20264:06 pmRNSBoard Change
2nd Mar 20261:39 pmRNSShareholder update & PDMR Dealing
2nd Mar 20267:00 amRNSDirectorate change
30th Jan 20261:00 pmRNSBoard Committee and Change of Role Update
20th Jan 20267:00 amRNSTrading Update
12th Jan 20264:45 pmRNSAppointment of Joint Corporate Broker
2nd Dec 20257:00 amRNSInterim Results
20th Nov 202511:45 amRNSHolding(s) in Company
24th Oct 20253:28 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSTrading Update
14th Oct 20259:16 amRNSCapital Markets Day
6th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSDirector/PDMR Shareholding - replacement
29th Sep 20255:48 pmRNSDirector/PDMR Shareholding
29th Sep 20251:27 pmRNSHolding(s) in Company
26th Sep 20252:29 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
24th Sep 20253:01 pmRNSResult of AGM
23rd Sep 20257:00 amRNSTrading Update
15th Sep 20251:00 pmRNSDirector/PDMR Shareholding
27th Aug 20254:51 pmRNSNotice of AGM
8th Aug 20254:35 pmRNSDirector/PDMR Shareholding
9th Jul 20257:00 amRNSDirector Role Change
9th Jul 20257:00 amRNSFinal Results
9th Jul 20257:00 amRNSTrading Update
4th Jul 202511:45 amRNSHolding(s) in Company
4th Jul 20257:00 amRNSHolding(s) in Company
16th Jun 20251:30 pmRNSHolding(s) in Company
14th May 20257:00 amRNSEstablishment of New Long-Term Incentive Plan
24th Apr 20251:53 pmRNSHolding(s) in Company
23rd Apr 20257:00 amRNSTrading Statement
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Update
8th Jan 202510:15 amRNSHolding(s) in Company
3rd Dec 20247:00 amRNSInterim Results
28th Nov 20247:00 amRNSInterim Results Presentation
21st Nov 20243:31 pmRNSHolding(s) in Company
28th Oct 202410:15 amRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.